Skip to main content
GOODWILL E-HEALTH INFO CO., LTD. logo

GOODWILL E-HEALTH INFO CO., LTD. — Investor Relations & Filings

Ticker · 688246 ISIN · CNE1000055V0 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 569 across all filing types
Latest filing 2023-12-29 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688246

About GOODWILL E-HEALTH INFO CO., LTD.

https://www.bjgoodwill.com/

Goodwill E-Health Info Co., Ltd. specializes in the development and implementation of comprehensive healthcare information technology solutions. The company focuses on digitalizing clinical workflows through its core offerings, which include advanced Hospital Information Systems (HIS), Electronic Medical Record (EMR) systems, and Clinical Information Systems (CIS). Its product suite is designed to enhance hospital management efficiency, improve patient safety, and facilitate data-driven clinical decision-making. Goodwill E-Health also provides regional healthcare information platforms that enable data sharing and interoperability across multiple medical institutions. By leveraging big data and cloud computing, the company supports the construction of smart hospitals and integrated healthcare networks, catering primarily to large-scale medical centers and public health organizations seeking digital transformation.

Recent filings

Filing Released Lang Actions
华泰联合证券有限责任公司关于嘉和美康（北京）科技股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed opinion and verification report from a securities firm (华泰联合证券有限责任公司) regarding the use of temporarily idle raised funds by 嘉和美康(北京)科技股份有限公司 for cash management. It references regulatory rules about the management and use of raised funds, details the amount and purpose of the raised funds, the investment products to be used, risk analysis, and the approval process by the company's board and supervisory committee. The document is not a full financial report but rather a regulatory compliance and verification statement related to the use of raised funds. It does not contain financial statements or earnings data, nor is it a brief announcement or a certification letter. It fits best as a Regulatory Filing (RNS) because it is a compliance-related disclosure that does not fit into other specific categories like Capital/Financing Update or Audit Report. The document length is 3251 characters, which is relatively short but contains substantive content about regulatory compliance and fund usage verification, not just an announcement of a report publication.
2023-12-29 Chinese
华泰联合证券有限责任公司关于嘉和美康（北京）科技股份有限公司使用部分超募资金归还银行贷款和永久补充流动资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Huatai United Securities regarding the use of part of the over-raised funds by Jiahe Meikang (Beijing) Technology Co., Ltd. to repay bank loans and permanently supplement working capital. It references regulatory approvals, fundraising details, board and shareholder meeting approvals, and compliance with relevant securities regulations. The document is not a financial report itself but an audit or verification opinion related to the use of funds raised in an IPO. It does not contain financial statements or earnings data but focuses on compliance and due diligence regarding the use of raised capital. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit/verification report on a specific financial matter, not a full annual or interim report, nor a simple announcement or certification. The document length is 3152 characters, which is relatively short but contains substantive content beyond a mere announcement or certification, so it is not RPA or RNS. Therefore, the best classification is AR with high confidence. FY 2023
2023-12-29 Chinese
嘉和美康关于2022年股票期权与限制性股票激励计划预留授予部分第一个归属期归属条件成就的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the 2022 stock option and restricted stock incentive plan of 嘉和美康(北京)科技股份有限公司. It includes specifics about the stock option and restricted stock grants, vesting conditions, performance targets, approval procedures, and the achievement of vesting conditions for the reserved portion of the incentive plan. The content is focused on the company's equity incentive plan, its implementation, and related board and supervisory committee approvals. This type of document is an official announcement about the achievement of conditions related to stock incentives and the related board resolutions. It is not a financial report, earnings release, or management discussion. It is also not a proxy solicitation or remuneration report. The document is an announcement of a corporate action related to stock incentives, which fits best under the category of Regulatory Filings (RNS) as it is a regulatory disclosure about stock incentive plan progress and approvals, not a full report or financial statement.
2023-12-29 Chinese
嘉和美康关于注销2022年股票期权与限制性股票激励计划部分股票期权的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the cancellation of part of the 2022 stock option and restricted stock incentive plan by the company 嘉和美康(北京)科技股份有限公司. It details the board and supervisory meetings that approved the cancellation, the legal and financial advisor opinions, and the impact on the company. The document is a formal announcement of a corporate action related to stock options and incentive plans, not a full financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but rather disclosures about stock option cancellations and related approvals. This fits best under the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-29 Chinese
嘉和美康关于作废2022年股票期权与限制性股票激励计划部分已授予尚未归属的限制性股票的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 嘉和美康(北京)科技股份有限公司 regarding the cancellation of part of the 2022 stock option and restricted stock incentive plan, specifically the cancellation of some granted but unvested restricted stocks. It details the board and supervisory meetings, approvals, legal opinions, and financial advisor opinions related to this cancellation. The document is a formal announcement about changes in the company's stock incentive plan and does not contain financial statements or detailed financial performance data. It is not a full annual or interim report, nor is it a regulatory certification or a voting result announcement. The content fits best under a regulatory announcement category related to corporate governance and stock incentive plan updates but does not match the exact governance information (CGR) or remuneration information (DEF 14A) categories since it focuses on cancellation of stock incentives rather than compensation details. Given the nature of the announcement and its regulatory compliance content, the best fit is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-12-29 Chinese
嘉和美康关于使用部分暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement by 嘉和美康(北京)科技股份有限公司 regarding the use of temporarily idle raised funds for cash management. It details the board and supervisory meetings approving the use of up to 4 billion RMB of idle raised funds for purchasing safe, liquid, and principal-guaranteed investment products. The document includes background on the raised funds, previous approvals, investment purpose, risk analysis, and opinions from the supervisory board and the sponsoring institution. It is a regulatory announcement about the company's financing and capital management activities, specifically the use of raised funds, but it does not contain financial statements or detailed financial results. The document length is 3726 characters, which is relatively short and consistent with an announcement rather than a full report. It is not an annual or interim report, audit report, earnings release, or other detailed financial report. It is best classified as a Capital/Financing Update (CAP) because it updates on the company's use of raised capital and cash management activities.
2023-12-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.